A third HSAN5 mutation disrupts the nerve growth factor furin cleavage site.
cam.issuedOnline | 2018-10-08 | |
dc.contributor.author | Shaikh, Samiha S | |
dc.contributor.author | Nahorski, Michael S | |
dc.contributor.author | Woods, C Geoffrey | |
dc.contributor.orcid | Shaikh, Samiha S [0000-0002-9757-6529] | |
dc.date.accessioned | 2018-11-23T00:32:53Z | |
dc.date.available | 2018-11-23T00:32:53Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Bi-allelic dysfunctional mutations in nerve growth factor (NGF) cause the rare human phenotype hereditary sensory and autonomic neuropathy type 5 (HSAN5). We describe a novel NGF mutation in an individual with typical HSAN5 findings. The mutation c.361C>T, p.R121W is at the last residue of the furin cleavage motif Arg-Ser-Lys-Arg in proNGF. We show that the p.R121W mutation completely abolishes the formation of mature NGF-β. Surprisingly, mutant p.R121W cells produced very little proNGF. Instead, the two progressive cleavage products of proNGF were produced, proA-NGF and proB-NGF, with proB-NGF being the predominant NGF-derived peptide and the only peptide secreted by mutant p.R121W cells. We found that the ability of the p.R121W mutation to cause tropomyosin receptor kinase A autophosphorylation and mitogen-activated protein kinase phosphorylation was significantly reduced compared to controls (p < 0.05 and p < 0.01). By studying the PC12 cell line morphology and neurite length over a week, we found the p.R121W mutation had residual, but much reduced, neurotrophic activity when compared to wild-type NGF. Finally, we assessed whether the p.R121W mutation affected apoptosis and found a reduced protective effect compared to wild-type NGF. Our results suggest that the p.R121W NGF mutation causes HSAN5 through negating the ability of furin to cleave proNGF to produce NGF-β. | |
dc.description.sponsorship | SSS was funded by the UK Medical Research Council (MR/K017551/1), and MSN by the Wellcome Trust (200183/Z/15/Z). | |
dc.format.medium | Print-Electronic | |
dc.identifier.doi | 10.17863/CAM.33180 | |
dc.identifier.eissn | 1744-8069 | |
dc.identifier.issn | 1744-8069 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/285836 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | SAGE Publications | |
dc.publisher.url | http://dx.doi.org/10.1177/1744806918809223 | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.subject | HSAN5 | |
dc.subject | Nerve growth factor | |
dc.subject | furin cleavage | |
dc.subject | mutation | |
dc.subject | Animals | |
dc.subject | Hereditary Sensory and Autonomic Neuropathies | |
dc.subject | Mutation | |
dc.subject | Nerve Growth Factor | |
dc.subject | Neurites | |
dc.subject | Neurons | |
dc.subject | PC12 Cells | |
dc.subject | Phosphorylation | |
dc.subject | Protein Precursors | |
dc.subject | Rats | |
dc.title | A third HSAN5 mutation disrupts the nerve growth factor furin cleavage site. | |
dc.type | Article | |
dcterms.dateAccepted | 2018-09-20 | |
prism.publicationDate | 2018 | |
prism.publicationName | Mol Pain | |
prism.startingPage | 1744806918809223 | |
prism.volume | 14 | |
pubs.funder-project-id | MRC (MR/K017551/1) | |
pubs.funder-project-id | Wellcome Trust (via University College London (UCL)) (532344) | |
rioxxterms.licenseref.startdate | 2018-01 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.type | Journal Article/Review | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1177/1744806918809223 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 1744806918809223.pdf
- Size:
- 701.22 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- https://creativecommons.org/licenses/by/4.0/
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- DepositLicenceAgreementv2.1.pdf
- Size:
- 150.9 KB
- Format:
- Adobe Portable Document Format